Search
Login
My Portfolios Login
TradeMachine® Login
CML Research Pro Login
Get TradeMachine®
Get CML Research
Compare Products
Home
My Portfolios
CMLViz News
Breaking
Stock
Scanner
Tear Sheet
News
Profile
Stats
Stock Chart
Pivot Points
Financial Charts
Holders
Analysts
Day Trader
Back-Tester
SPX
3,911.74
+124.00
(
+3.17%
)
Dow 30
+2.73%
QQQ
+3.56%
VIX
27.23
-1.82
(
-6.27%
)
ANI Pharmaceuticals Inc
NASDAQ:ANIP
28.85
+1.63
(
+5.99%
)
Products
ANI Pharma Announces FDA Approval And Imminent Launch Of Clorazepate Dipotassium Tablets USP
Published: 06/22/2022 11:26 GMT
ANIP
ANI Pharmaceuticals Inc (
ANIP
)
- Ani Pharmaceuticals Announces FDA Approval and Imminent Launch of Clorazepate Dipotassium Tablets Usp.